A drug molecule invented by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.
The medicine was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
The drug will be used to treat patients who have obsessive-compulsive disorder (OCD) also called as Anxiety disorder.
Inspite of drug development takes about five years to get to trial, but the AI drug took just 12 months.That's the growth of Artificial Intelligence.
Exscienta chief executive Prof Andrew Hopkins described it as a "key milestone in drug discovery".
The molecule - known as DSP-1181 - was created by using algorithms that sifted through potential compounds, checking them against a huge database of parameters.
By
KISHORE
Post a Comment